Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
130M
-
Number of holders
-
164
-
Total 13F shares, excl. options
-
78.3M
-
Shares change
-
+11.7M
-
Total reported value, excl. options
-
$1.2B
-
Value change
-
+$181M
-
Put/Call ratio
-
0.09
-
Number of buys
-
89
-
Number of sells
-
-60
-
Price
-
$15.35
Significant Holders of NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) as of Q3 2018
180 filings reported holding NEO - NEOGENOMICS INC - Common Stock, par value $0.001 per share as of Q3 2018.
NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) has 164 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 78.3M shares
of 130M outstanding shares and own 60.36% of the company stock.
Largest 10 shareholders include GENERAL ELECTRIC CO (15M shares), JANUS HENDERSON GROUP PLC (6.1M shares), BlackRock Inc. (5.08M shares), Vanguard Group Inc (3.84M shares), First Light Asset Management, LLC (3.7M shares), EAGLE ASSET MANAGEMENT INC (2.16M shares), CARILLON TOWER ADVISERS, INC. (2M shares), Granite Investment Partners, LLC (1.68M shares), EMERALD ADVISERS INC/PA (1.67M shares), and Russell Investments Group, Ltd. (1.66M shares).
This table shows the top 164 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.